Seroprevalance of Bordetella pertussis antibodies among healthy adolescent girls in Edirne

Basit Öğe Kaydı
dc.authoridÇöplü, Nilay/0000-0003-1956-1417
dc.authorwosidÇöplü, Nilay/ABR-8131-2022
dc.contributor.authorVatansever, U
dc.contributor.authorÇöplü, N
dc.contributor.authorÖner, N
dc.contributor.authorSönmez, C
dc.contributor.authorKarasalihoglu, S
dc.contributor.authorKurtoglu, D
dc.contributor.authorEsen, B
dc.date.accessioned2024-06-12T11:07:08Z
dc.date.available2024-06-12T11:07:08Z
dc.date.issued2005
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective: Immune response against pertussis can be induced by infection and/or vaccination and vaccine induced immunity is known to wane within the decade following vaccination. Our aim was to assess the pertussis immune response among adolescent girls in the province of Edirne in Turkey. In addition we determined the relationship between the immune response and age, residence, and vaccination status. Material and methods: Serum samples were collected from 3 59 adolescent girls, 12 to 17 years old. The subjects were selected by systematic randomisation from school rosters and sampled by age and urban-rural residence strata proportional to the corresponding distributions in the Edirne population. Pertussis immunity was determined by an in-house quantitative ELISA method for anti-PT and anti-FHA antibodies. Results: Protective levels of antibody (>10 EU/ml) for anti-pertussis toxin and anti-filamentons heamagglutinin were found in 95.3% and 97.2% of the overall study group respectively. In 12- to 14-year-olds protective levels were shown in 94.1% and 97.0%, in 15- to 17-year-olds in 97.5% and 97.5%, In rural areas in 96.7% and 97.5%, and in urban areas in 94.5% and 97.5%, respectively (p >0.05). Conclusion: The high percentages of protective levels of antibodies in our study population might be an indicator of previous infections, which are a threat to infants who have not completed primary immunisation. In this respect, adult immunisation should be considered.en_US
dc.identifier.endpage536en_US
dc.identifier.issn1424-7860
dc.identifier.issn1424-3997
dc.identifier.issue35-36en_US
dc.identifier.pmid16323071en_US
dc.identifier.scopus2-s2.0-27644501311en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage531en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21919
dc.identifier.volume135en_US
dc.identifier.wosWOS:000233031400006en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherE M H Swiss Medical Publishers Ltden_US
dc.relation.ispartofSwiss Medical Weeklyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectImmunityen_US
dc.subjectAdolescent Girlsen_US
dc.subjectPertussisen_US
dc.subjectTurkeyen_US
dc.subjectSeroepidemiologyen_US
dc.subjectVaccinationen_US
dc.titleSeroprevalance of Bordetella pertussis antibodies among healthy adolescent girls in Edirneen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu